OTC Marketing Should Focus On Safety, Not Efficacy – Novartis VP
This article was originally published in The Tan Sheet
Executive Summary
Safety claims should take priority over proof of efficacy in marketing of OTC drugs, according to Novartis VP-Clinical & Medical Development Helmut Albrecht, MD